{
    "id": "correct_subsidiary_00058_0",
    "rank": 46,
    "data": {
        "url": "https://www.lawinsider.com/dictionary/elan-intellectual-property",
        "read_more_link": "",
        "language": "en",
        "title": "Elan Intellectual Property Definition",
        "top_image": "https://www.lawinsider.com/images/common/law-insider-og-image.png",
        "meta_img": "https://www.lawinsider.com/images/common/law-insider-og-image.png",
        "images": [],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Define Elan Intellectual Property. has the meaning assigned thereto in the Elan License Agreement.",
        "meta_lang": "en",
        "meta_favicon": "/images/touch/apple-icon-60x60.png",
        "meta_site_name": "Law Insider",
        "canonical_link": null,
        "text": "Expect as expressly set forth in Article 2.2, nothing in this Agreement will impair Acorda’s right to independently acquire, license, develop for itself, or have others develop for it, intellectual property and technology performing similar functions as the Elan Intellectual Property or to market and distribute products based on such other intellectual property and technology.\n\nSubject to the provisions of Article 12.1 Elan may use the Elan Intellectual Property and all technical and clinical data or improvements generated by Elan pursuant to this Agreement in connection with Elan’s commercial arrangements for the Product in any country which ceases to be a part of the Territory, or in relation to the Product in the Territory in the event of the termination of this Agreement.\n\nElan agrees to hold Acorda harmless from any and all costs, expenses and damages (including reasonable attorneys’ fees) incurred or sustained by Acorda as the result of any Third Party’s challenges to Elan’s right to enter into this Agreement and to grant the rights and licences herein granted to Acorda and the Elan Intellectual Property.\n\nElan is and shall remain the owner of the Elan Intellectual Property and Elan Oral Controlled Release Patents.\n\nSubject to the terms of this Agreement and the terms of the Commercial Manufacture and Supply Agreement, Elan hereby grants to Zogenix a non-exclusive license under the Elan Intellectual Property to make or have made the Product in the Field in the Territory (the “Manufacturing License”), which Zogenix shall not be entitled to utilize except where there is a Failure to Supply."
    }
}